Brittney N. Newby

Pediatrics
3401 Civic Center Blvd
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study.

HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study.

Journal: ACR open rheumatology
Published: March 17, 2026

Advancing Juvenile Spondyloarthritis: Closing Knowledge Gaps with New Axial JSpA Classification Criteria.

Advancing Juvenile Spondyloarthritis: Closing Knowledge Gaps with New Axial JSpA Classification Criteria.

Journal: Current rheumatology reports
Published: August 12, 2025

Implementation of a Trauma-Informed Challenging Interactions Reporting Tool to Improve our Clinical Learning Environment.

Implementation of a Trauma-Informed Challenging Interactions Reporting Tool to Improve our Clinical Learning Environment.

Journal: Academic pediatrics
Published: October 23, 2023

NADPH Oxidase 2-Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function.

NADPH Oxidase 2-Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 19, 2022

Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes.

Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes.

Journal: Frontiers in endocrinology
Published: July 06, 2021

Innate inflammation drives NK cell activation to impair Treg activity.

Innate inflammation drives NK cell activation to impair Treg activity.

Journal: Journal of autoimmunity
Published: October 28, 2019

Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Journal: Current diabetes reports
Published: September 01, 2018

Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment.

Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment.

Journal: Frontiers in endocrinology
Published: June 29, 2017

Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes.

Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes.

Journal: Frontiers in immunology
Published: June 15, 2017

Type 1 Interferons Potentiate Human CD8+ T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent Pathway.

Type 1 Interferons Potentiate Human CD8+ T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent Pathway.

Journal: Diabetes
Published: January 23, 2017

Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes.

Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes.

Journal: Diabetes
Published: July 12, 2016

Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment.

Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment.

Journal: Cancer research
Published: June 29, 2016
Showing 1-12 of 13

Last Updated: 09/26/2026